High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

(2009) Jérôme Toussaint et al.   BMC GENOMICS

Evaluation of methods for amplification of picogram amounts of total RNA for whole genome expression profiling

(2009) Mathieu Clément-Ziza et al.   BMC GENOMICS

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

(2009) Christine Desmedt et al.   BMC Medical Genomics

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

(2009) Koji Morimoto et al.   CANCER SCIENCE

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer

(2009) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of prognostic gene expression signatures for breast cancer

(2008) Benjamin Haibe-Kains et al.   BMC GENOMICS